(Q33560095)

28 July 2017

1 reference

title

Cyclosporin: a pharmacoeconomic evaluation of its use in renal transplantation (English)

1 reference

28 July 2017

1 reference

Frampton JE

1

1 reference

28 July 2017

Faulds D

series ordinal

2

1 reference

28 July 2017

publication date

1 November 1993

1 reference

28 July 2017

1 reference

28 July 2017

volume

4

1 reference

28 July 2017

issue

5

1 reference

28 July 2017

page(s)

366-395

1 reference

Fixed-rate reimbursement fails to cover costs for patients with delayed graft function

28 July 2017

cites work

1 reference

12 December 2020

The utility of cyclosporine weaning in renal transplantation

1 reference

12 December 2020

Economic impact of noncompliance in kidney transplant recipients

1 reference

12 December 2020

Post-transplant hypertension

1 reference

12 December 2020

Risk factors for chronic rejection in renal allograft recipients.

1 reference

12 December 2020

Renal transplantation for older patients.

1 reference

12 December 2020

A randomized trial of cyclosporine and prednisolone versus cyclosporine, azathioprine, and prednisolone in primary cadaveric renal transplantation

1 reference

12 December 2020

Lipid abnormalities in renal disease

1 reference

12 December 2020

An evaluation of early cyclosporine versus ALG therapy for primary cadaver renal allografts with immediate function

1 reference

12 December 2020

Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation

1 reference

12 December 2020

Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients

1 reference

12 December 2020

Psychosocial profile of noncompliant transplant patients

1 reference

12 December 2020

Tapering or discontinuing cyclosporine for financial reasons--a single-center experience

1 reference

12 December 2020

Cost-effective care of end-stage renal disease: a billion dollar question

1 reference

12 December 2020

A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years

1 reference

12 December 2020

Epoetin: a pharmacoeconomic review of its use in chronic renal failure and its effects on quality of life

1 reference

12 December 2020

Prospective study of the safety and financial benefit of ketoconazole as adjunctive therapy to cyclosporine after heart transplantation

1 reference

12 December 2020

Cyclosporine-ketoconazole interaction. Long-term follow-up and preliminary results of a randomized trial

1 reference

12 December 2020

Evidence against chronic progressive cyclosporine nephrotoxicity

1 reference

12 December 2020

Effect of steroid withdrawal on hypertension and cholesterol levels in living related recipients

1 reference

12 December 2020

Predicting Treatment Costs and Life Expectancy for End-Stage Renal Disease

1 reference

12 December 2020

Cyclosporin and serum lipids in renal transplant recipients

1 reference

12 December 2020

Pathophysiology and treatment of posttransplant hypertension

1 reference

12 December 2020

Costs and benefits of cyclosporine therapy in renal transplantation

1 reference

12 December 2020

Impact of long-term immunosuppression with cyclosporin A on serum lipids in stable renal transplant recipients

1 reference

12 December 2020

One-hundred and five cadaveric kidney transplants with cyclosporine in recipients more than 60 years of age

1 reference

12 December 2020

An increased incidence of late acute rejection episodes in cadaver renal allograft recipients given azathioprine, cyclosporine, and prednisone

1 reference

12 December 2020

Cyclosporin and ketoconazole, drug interaction or therapeutic association?

1 reference

12 December 2020

Cost containment: coadministration of diltiazem with cyclosporine after heart transplantation

1 reference

12 December 2020

Lipid disorders in renal transplant recipients

1 reference

12 December 2020

Cyclosporine-associated chronic nephropathy

1 reference

12 December 2020

Improved cadaveric renal transplant outcome in children

1 reference

12 December 2020

Long-term renal allograft function under maintenance immunosuppression with cyclosporin A or azathioprine. A single center, five-year follow-up study

1 reference

12 December 2020

1 reference

12 December 2020

Prevalence and cost of ESRD therapy

1 reference

12 December 2020

Conversion from cyclosporine: status after five years

1 reference

12 December 2020

1 reference

12 December 2020

The quality of life of patients with end-stage renal disease

1 reference

12 December 2020

Quality of life after kidney transplantation. A prospective, randomized comparison of cyclosporine and conventional immunosuppressive therapy.

1 reference

12 December 2020

The plasma creatinine concentration is not an accurate reflection of the glomerular filtration rate in stable renal transplant patients receiving cyclosporine

1 reference

12 December 2020

Preference based outcome measures for economic evaluation of drug interventions: quality adjusted life years (QALYs) versus healthy years equivalents (HYEs)

1 reference

12 December 2020

Elective cyclosporine withdrawal after renal transplantation. A meta-analysis

1 reference

12 December 2020

A comparison of different methods of estimating glomerular filtration rate in cyclosporine-treated renal transplant patients

1 reference

12 December 2020

Influence of cyclosporine on posttransplant blood pressure response

1 reference

12 December 2020

Measurement of quality of life in end-stage renal disease: the time trade-off approach.

1 reference

12 December 2020

Immunosuppressive drugs in renal transplantation. A review of the regimens

1 reference

12 December 2020

Quality of life after heart transplantation in patients assigned to double- or triple-drug therapy

1 reference

12 December 2020

Results of conversion from cyclosporine to azathioprine in cadaveric renal transplantation

1 reference

12 December 2020

Economic impact of cyclosporine in transplantation

1 reference

12 December 2020

Costs and financing of kidney transplantation in the United States

1 reference

12 December 2020

Distinguishing the causes of post-transplantation hypertension

1 reference

12 December 2020

Assessment of alternative technologies for the treatment of end-stage renal disease

1 reference

12 December 2020

Long-term results with conversion from cyclosporine to azathioprine at 3 months after renal transplantation

1 reference

12 December 2020

Cost analysis of alternative treatments in end-stage renal disease

1 reference

12 December 2020

Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders

1 reference

12 December 2020

A pharmacoeconomic intrapatient comparison of Sandimmune capsules and Sandimmune oral solution in kidney transplant recipients

1 reference

12 December 2020

Cyclosporin and calcium channel blockers: an exploitable drug interaction?

1 reference

12 December 2020

On the intraindividual variability and chronobiology of cyclosporine pharmacokinetics in renal transplantation

1 reference

12 December 2020

Beneficial effect of cyclosporine on renal transplantation. A multicenter long-term study

1 reference

12 December 2020

Conversion from cyclosporine to azathioprine improves renal function without increased risk of graft failure

1 reference

12 December 2020

Life or death. The issue of payment in cadaveric organ donation

1 reference

12 December 2020

Renal transplant function after ten years of cyclosporine

1 reference

12 December 2020

Who should be converted from cyclosporine to conventional immunosuppression in kidney transplantation, and why

1 reference

12 December 2020

Significance of delayed graft function in cyclosporine-treated recipients of cadaver kidney transplants

1 reference

12 December 2020

The impact of center variation on the HLA-DR matching effect in kidney graft survival

1 reference

12 December 2020

The association of cyclosporine with the 1-year costs of cadaver-donor kidney transplants

1 reference

12 December 2020

Cyclosporin in cadaveric renal transplantation: 5-year follow-up of a multicentre trial

1 reference

12 December 2020

Comparison of antilymphocyte globulin and continuous i.v. cyclosporine A as induction immunosuppression for cadaver kidney transplants: a prospective randomized study

1 reference

12 December 2020

The effect of cyclosporine on the use of hospital resources for kidney transplantation

1 reference

12 December 2020

Long-term follow-up in London Transplant Group recipients of cadaver renal allografts. The influence of HLA matching on transplant outcome

1 reference

12 December 2020

Limitations of creatinine in quantifying the severity of cyclosporine-induced chronic nephropathy

1 reference

12 December 2020

A randomized study of cyclosporine with and without prednisone in renal allograft recipients. Canadian Transplant Group

1 reference

12 December 2020

More favorable clinical course in kidney allograft recipients due to HLA-B+ DR matching.

1 reference

12 December 2020

Long-term graft survival after conversion from cyclosporin to azathioprine 1 year after renal transplantation. A prospective, randomized study from 1 to 6 years after transplantation

1 reference

12 December 2020

Sequential antilymphoblast globulin and cyclosporine for renal transplantation

1 reference

12 December 2020

A randomized trial comparing double-drug and triple-drug therapy in primary cadaveric renal transplants

1 reference

12 December 2020

Incidence of advanced chronic renal failure and the need for end stage renal replacement treatment

1 reference

12 December 2020

Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone

1 reference

12 December 2020

Is retransplantation cost effective?

1 reference

12 December 2020

T-lymphocyte-antigen interactions in transplant rejection

1 reference

12 December 2020

Noncompliance in organ transplant recipients.

1 reference

12 December 2020

Kidney transplantation in older patients.

1 reference

12 December 2020

Cancer development in renal allograft recipients treated with conventional and cyclosporine immunosuppression

1 reference

12 December 2020

Cadaveric Renal Transplantation With Cyclosporin-A and Steroids.

1 reference

12 December 2020

The case against the indefinite use of cyclosporine

1 reference

12 December 2020

Clinical and experimental studies with cyclosporine in renal transplantation

1 reference

12 December 2020

An economic analysis of liver transplantation. Costs, insurance coverage, and reimbursement

1 reference

12 December 2020

Survival into the second decade following kidney transplantation in type I diabetic patients

1 reference

12 December 2020

Selectivity still has its price: personal experiences with cyclosporine over the last 10 years

1 reference

12 December 2020

Cyclosporine concentration determinations for monitoring and pharmacokinetic studies

1 reference

12 December 2020

The Medicare experience with end-stage renal disease: trends in incidence, prevalence, and survival

1 reference

12 December 2020

The cost impact of cytomegalovirus disease in renal transplant recipients.

1 reference

12 December 2020

Patients With a Low Income Have Reduced Renal Allograft Survival

1 reference

12 December 2020

Post-transplant conversion from cyclosporin to azathioprine: effect on cardiovascular risk profile

1 reference

12 December 2020

Immunosuppressive therapy as a determinant of transplantation outcomes.

1 reference

12 December 2020

A controlled, double-blind, randomized trial of verapamil and cyclosporine in cadaver renal transplant patients

1 reference

12 December 2020

Remarkable long-term prognosis and excellent growth in kidney-transplant children under cyclosporine monotherapy

1 reference

12 December 2020

Lipid metabolic abnormalities after renal transplantation under cyclosporine and prednisone immunosuppression

1 reference

12 December 2020

A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years

1 reference

12 December 2020

Effect of transplantation on the Medicare end-stage renal disease program

1 reference

12 December 2020

Side effects and safety of Sandimmun in long-term treatment of renal transplant patients

1 reference

12 December 2020

A Randomized Clinical Trial of Cyclosporine in Cadaveric Renal Transplantation

1 reference

12 December 2020

1 reference

12 December 2020

Cyclosporin in cadaveric renal transplantation: one-year follow-up of a multicentre trial

1 reference

12 December 2020

Cancers after cyclosporine therapy

1 reference

12 December 2020

Which renal transplant patients should receive cytomegalovirus immune globulin? A cost-effectiveness analysis

1 reference

12 December 2020

A randomized prospective trial comparing cyclosporine monotherapy with triple-drug therapy in renal transplantation

1 reference

12 December 2020

The present and future of kidney transplantation

1 reference

12 December 2020

Elective cyclosporine withdrawal in renal transplant recipients maintained on triple therapy

1 reference

12 December 2020

A study of treatment compliance following kidney transplantation.

1 reference

12 December 2020

A cost-effectiveness analysis of cyclosporine in cadaveric kidney transplantation

1 reference

12 December 2020

Picking up the tab for erythropoietin

1 reference

12 December 2020

First report of an Australian randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and cyclosporine+azathioprine+prednisolone in renal transplantation

1 reference

12 December 2020

Creatinine: an inadequate filtration marker in glomerular diseases

1 reference

12 December 2020

Should cyclosporine be continued indefinitely?

1 reference

12 December 2020

Renal transplantation in patients 65 years old or older

1 reference

12 December 2020

Cyclosporin clinical pharmacokinetics

1 reference

12 December 2020

Progress towards a molecular understanding of cyclosporin A-mediated immunosuppression

1 reference

12 December 2020

Superior long-term kidney graft survival in patients on maintenance immunosuppression with cyclosporine and azathioprine

1 reference

12 December 2020

Costs of immunosuppressive therapies used in renal transplantation

1 reference

12 December 2020

Dual vs triple immunosuppressive therapy: equally safe and effective in kidney transplantation?

1 reference

12 December 2020

Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine

1 reference

12 December 2020

1 reference

12 December 2020

Pharmacokinetics and nephrotoxicity of cyclosporine

1 reference

12 December 2020

Cyclosporin in cadaveric renal transplantation: 3-year follow-up of a European multicentre trial

1 reference

12 December 2020

Cadaveric kidney exchange on the basis of HLA-matching is already cost-effective in the first year after grafting

1 reference

12 December 2020

Comparison of treatment costs between dialysis and transplantation

1 reference

12 December 2020

Renal transplantation costs: an economic analysis and comparison with dialysis costs

1 reference

12 December 2020

Long-term impact of HLA matching on kidney graft survival in cyclosporine-treated recipients

1 reference

12 December 2020

Interaction between cyclosporine and felodipine in renal transplant recipients

1 reference

12 December 2020

The effect of cyclosporine on the use of hospital resources for kidney transplantation.

1 reference

12 December 2020

Diltiazem treatment with reduced dose of cyclosporine in renal transplant recipients

1 reference

12 December 2020

Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants

1 reference

12 December 2020

The pharmacoeconomics of renal transplantation: increased drug costs with decreased hospitalization costs

1 reference

12 December 2020

Relationship between clinical outcome, inpatient length of stay, and cost of renal transplantation at four US transplant centers

1 reference

12 December 2020

Transplantation and home hemodialysis: their cost-effectiveness

1 reference

12 December 2020

Diltiazem in renal allograft recipients receiving cyclosporine

1 reference

12 December 2020

Risk factors for accelerated atherosclerosis in renal transplant recipients

1 reference

12 December 2020

Social support, family variables, and compliance in renal transplant children

1 reference

12 December 2020

Effects of three immunosuppressive drug protocols on cadaver renal transplantation costs after 4 years of therapy

1 reference

12 December 2020

Long-term outlook for renal transplant recipients with one-year function. "Doctor, what are my chances"?

1 reference

12 December 2020

Report on management of renal failure in Europe, XXII, 1991

1 reference

12 December 2020

Causes of late renal allograft failure in the ciclosporin era

1 reference

12 December 2020

Does cyclosporin increase lipoprotein(a) concentrations in renal transplant recipients?

1 reference

12 December 2020

Optimisation of immunosuppressive therapy using pharmacokinetic principles

1 reference

12 December 2020

Transplantation immunology

1 reference

12 December 2020

Renal side-effects of cyclosporin A.

1 reference

12 December 2020

An alternative view minimizing the significance of cyclosporine nephrotoxicity and in favor of enhanced immunosuppression for long-term kidney transplant recipients

1 reference

12 December 2020

Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients

1 reference

12 December 2020

Prospective randomized comparison of quadruple vs triple therapy for first cadaver transplants with immediate function

1 reference

12 December 2020

Long-term safety profile of sandimmune in renal transplantation

1 reference

12 December 2020

HLA-DR matching is effective in reducing posttransplant costs in renal allograft recipients on triple therapy

1 reference

12 December 2020

The beneficial effects of isradipine on renal hemodynamics in cyclosporine-treated renal transplant recipients

1 reference

12 December 2020

Maintenance immunosuppression therapy and outcome of renal transplantation in North American children--a report of the North American Pediatric Renal Transplant Cooperative Study

1 reference

12 December 2020

Quality-of-life issues for end-stage renal disease patients

1 reference

12 December 2020

Cyclosporine and the liver: how one affects the other

1 reference

12 December 2020

10.2165/00019053-199304050-00007

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

1007457197

0 references

1 reference